Glucocorticoids and Hypertension in Man

References

• Whitworth J. A. Cushing's syndrome and hypertension. Textbook of Hypertension, J. D. Swales. Blackwell Scientific Publications. 1994; 893–903
   Google Scholar
• Vermeulen A., Van der Straeten M. Adrenal cortical function in benign essential hypertension. J Clin Endocrinol Metab. 1963; 23: 574–578
   PubMed Web of Science ®Google Scholar
• Ulick S., Levine L. S., Gunczler P., Zanconato G., Ramirez L. C., Rauh W., Rosler A., Bradlow H. L., New M. I. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab. 1979; 49: 757–764
   PubMed Web of Science ®Google Scholar
• Stewart P. M., Corrie J. E.T., Shackleton C. H.L., Edwards C. R.W. The syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest. 1988; 82: 340–349
   PubMed Web of Science ®Google Scholar
• Speiser P. W., Riddick L. M., Martin K., New M. I. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess. Metabolism 1993; 42: 843–845
   PubMed Web of Science ®Google Scholar
• Wilson R. C., Krozowski Z. S., Li K., et al. A mutation in the HSDB2 gene in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 1995; 80: 2263–2266
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Kelly J. J. Journal Club. Evidence that high dose cortisol induced sodium retention in man is not mediated by the mineralocorticoid receptor. J Endocrinol Invest. 1995; 18: 586–591
   Google Scholar
• Stewart P. M., Valentino R., Wallace A. M., Burt D., Shackleton C. H.L., Edwards C. R.W. Mineralocorticoid activity of liquorice: 11β-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987; II: 821–824
   Google Scholar
• Whitworth J. A., Stewart P. M., Burt D., Atherden S. M., Edwards C. R.W. The kidney is a major site of cortisone metabolism. Clin Endocrinol. 1989; 31: 355–361
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Williamson P. M., Brown M. A., Edwards C. R.W. Haemodynamic and metabolic effects of carbenoxolone in normal subjects and patients with renal impairment. Clin Exp Hypertens. 1994; 16: 431–450
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Gordon D., McLachlan-Troup N., Scoggins B. A., Moulds R. W.F. Dexamethasone suppression in essential hypertension: Effects on cortisol and blood pressure. Clin Exp Hypertens. 1989; A11: 323–335
   Google Scholar
• Walker B. R., Stewart P. M., Padfield P. L., Edwards C. R.W. Increased vascular sensitivity to glucocorticoids in essential hypertension: 11β-hydroxysteroid dehydrogenase deficiency revisited. J Hypertens. 1991; 9: 1082–1083
   Google Scholar
• Walker B. R., Best R., Shackleton C. H.L., Padfield P. L., Edwards C. R.W. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 1996; 27: 190–196
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Scoggins B. A., Andrews J., Williamson P. M., Brown M. A. Haemodynamic and metabolic effects of short term administration of synthetic sex steroids in humans. Clin Exp Hypertens. 1992; A14: 905–922
   Google Scholar
• Sudhir K., Jennings G. L., Esler M. D., Korner P. I., Blombery P. A., Lambert G. W., Scoggins B., Whitworth J. A. Hydrocortisone-induced hypertension in humans: pressor responsiveness and sympathetic function. Hypertension 1989; 13: 416–421
   PubMed Web of Science ®Google Scholar
• Whitworth J. A. Studies on the mechanisms of glucocorticoid hypertension in humans. Blood Pressure 1994; 3: 24–32
   PubMedGoogle Scholar
• Connell J. M.C., Whitworth J. A., Davies D. L., Lever A. F., Richards A. M., Fraser R. Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. J Hypertens. 1987; 5: 425–433
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Saines D., Scoggins B. A. Blood pressure and metabolic effects of cortisol and deoxycorticosterone in man. Clin Exp Hypertens. (A) 1984; 6: 795–809
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Gordon D., Andrew S. J., Scoggins B. A. The hypertensive effect of synthetic glucocorticoids in man: role of sodium and volume. J Hypertens. 1989; 7: 537–549
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Scoggins B. A. A hypertensinogenic class of steroid hormone activity in man?. Clin Exp Pharmacol Physiol. 1990; 17: 163–166
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Williamson P. M., Brown M. A., Morris M. J. Neuropeptide Y in cortisol-induced hypertension in male volunteers. Clin Exp Pharmacol Physiol. 1994; 21: 435–438
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Williamson P. M., Brown M. A., Colman P. Hyperinsulinaemia is not a cause of cortisol-induced hypertension. Am J Hypertens. 1994; 7: 562–565
   PubMed Web of Science ®Google Scholar
• Williamson P. M., Kelly J. J., Whitworth J. A. Dose response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J. Hypertens. 1996, (In press).
   Web of Science ®Google Scholar
• Connell J. M.C., Whitworth J. A., Davies D. L., Richards A. M., Fraser R. Haemodynamic, hormonal and renal effects of ACTH in sodium restricted man. J Hypertens. 1988; 6: 17–23
   PubMed Web of Science ®Google Scholar
• Wong K. S., Williamson P. M., Brown M. A., Denton D. A., Whitworth J. A. Effects of cortisol on blood pressure and salt preference in normal man. Clin Exp Pharmacol Physiol. 1993; 20: 121–126
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Scoggins B. A., Connell J. M.C. Adrenocortical hypertension. Proceedings of 10th International Congress of Nephrology, A. M. Davison. Bailliere Tindall, 1988; 869–883
   Google Scholar
• Pirpiris M., Yeung S., Dewar E., Jennings G. L., Whitworth J. A. Hydrocortisone-induced hypertension in man: The role of cardiac output. Am J Hypertens. 1993; 6: 287–294
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Williamson P. M., Ramsay D. Haemodynamic responses to cortisol in man: Effects of felodipine. Hypertension Research 1994; 17: 137–142
   Google Scholar
• Macefield V. G., Williamson P. M., Wilson L. R., Kelly J. J., Whitworth J A. Suppression of muscle sympathetic vasoconstrictor activity during cortisol induced hypertension. In Preparation
   Google Scholar
• Tam S. H., Williamson P. M., Kelly J. J., Whitworth J. A. Autonomic blockade amplifies cortisol induced hypertension in man. Clin Exp Pharmacol Physiol. 1996, (In press).
   Web of Science ®Google Scholar
• Tam S. H., Kelly J. J., Williamson P. M., Whitworth J. A. Reflux sympathetic function in cortisol-induced hypertension in humans. Submitted. Clin Exp Hypertens
   Google Scholar
• Sudhir K., Jennings G. L., Esler M. D., Korner P. I., Blombery P. A., Lambert G., Scoggins B. A., Whitworth J. A. Hydrocortisone induced hypertension in humans: Pressor responsiveness and sympathetic function. Hypertension 1989; 13: 416–421
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Connell J. M.C., Lever A. F., Fraser R. Pressor responsiveness in steroid induced hypertension in man. Clin Exp Pharmacol Physiol. 1986; 13: 353–358
   PubMed Web of Science ®Google Scholar
• Connell J. M.C., Fisher B. M., Davidson G., Fraser R., Whitworth J. A. Effect of sodium depletion on pressor responsiveness in ACTH induced hypertension in man. Clin Exp Pharmacol Physiol. 1987; 14: 237–242
   PubMed Web of Science ®Google Scholar
• Whitworth J. A., Connell J. M.C., Gordon D., Scoggins B. A. Effects of indomethacin on steroid induced changes in pressor responsiveness in man. Clin Exp Pharmacol Physiol. 1988; 15: 305–310
   PubMed Web of Science ®Google Scholar